Answers are grounded in this paper and cite their sources.
The genus Magnolia, encompassing hundreds of globally distributed species, has a long-standing history in traditional medicine for treating diverse ailments. These species are particularly renowned for their rich array of bioactive compounds, notably alkaloids. This study provides a comprehensive summary of novel alkaloid compounds identified in various Magnolia species within recent years. Through a targeted literature review utilizing Google Scholar and PubMed (2002–2024), we pinpointed nine novel alkaloids and one nitrogen-based compound isolated from four distinct Magnolia species. These newly discovered compounds exhibited promising bioactivities, including significant antiplatelet and anti-acetylcholinesterase effects. Structurally, the majority of these compounds belong to the aporphine and benzylisoquinoline classes, although some display unique configurations, such as glycosidic or N-oxide alkaloids. This review aims to bridge a critical gap in the existing scientific literature regarding the comprehensive documentation of novel alkaloid secondary metabolites found across the diverse Magnolia genus.
No takes yet. Share an insight, caveat, or question.
Yuniarta et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: